2018 Article Archive
FDA approves new standard of care for kidney cancer
The U.S. Food and Drug Administration granted approval to the combination of two immunotherapy drugs, ipilimumab and nivolumab, for the treatment of metastatic kidney cancer.
Class Notes for April 2018
Comprehensive Class Notes from the April 2018 edition of Center Times.
Why alcohol, sugar lead to thirst
UT Southwestern researchers identify a hormone that acts on the brain to increase the desire to drink water in response to specific nutrient stresses that can cause dehydration.
Endocrinology team suppressing glycemic incidents
UT Southwestern’s inpatient diabetes program has helped lower incident rates of hypoglycemia and hyperglycemia to well below national levels.
Nijhawan selected to receive 2018 Seldin-Smith Award from ASCI
UT Southwestern’s Dr. Deepak Nijhawan became a co-recipient of the 2018 Donald Seldin-Holly Smith Award for Pioneering Research
Precision editing of gut bacteria: Potential way to treat colitis
UTSW researchers have used precision editing of the bacterial populations in the gut to prevent or reduce the severity of inflammation in a mouse model of colitis.
UT Southwestern selected as Patient Navigator Program: Focus MI Diplomat Hospital
Program aids hospitals in identifying best practices for keeping heart attack patients out of the hospital longer
UTSW researcher recognized with Lurie Prize in Biomedical Sciences
UT Southwestern Medical Center Professor Dr. Zhijian “James” Chen today became the recipient of the 2018 Lurie Prize in Biomedical Sciences for his discovery of the cGAS enzyme, a sensor of innate immunity. The enzyme patrols the cell’s interior and sounds the alarm to trigger the immune system in response to DNA.
Surgical oncologist Zeh named new Chair of Surgery
Dr. Herbert J. Zeh III, an innovator and leader in the field of pancreatic diseases and pancreatic cancer, has been selected as the next Chair of the Department of Surgery.
Pediatric cancer drug shows 93 percent response rate
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern’s Simmons Cancer Center announced.